arrow
Return

Indium Lung Disease

delete2012-06-01
delete104
delete
OA
AI
K
Kristin J. Cummings *
M
Makiko Nakano
K
Kazuyuki Omae
K
Koichiro Takeuchi
T
Tatsuya Chonan
Y
Yong-long Xiao
R
Russell A. Harley
V
Victor L. Roggli
A
Akira Hebisawa
R
Robert J. Tallaksen
B
Bruce C. Trapnell
G
Gregory A. Day
R
Rena Saito
M
Marcia Stanton
E
Eva Suarthana
K
Kathleen Kreiss
DOI:10.1378/chest.11-1880delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
Background: Reports of pulmonary fibrosis, emphysema, and, more recently, pulmonary alveolar proteinosis (PAP) in indium workers suggested that workplace exposure to indium compounds caused several different lung diseases. Methods: To better understand the pathogenesis and natural history of indium lung disease, a detailed, systematic, multidisciplinary analysis of clinical, histopathologic, radiologic, and epidemiologic data for all reported cases and workplaces was undertaken. Results: Ten men (median age, 35 years) who produced, used, or reclaimed indium compounds were diagnosed with interstitial lung disease 4-13 years after first exposure (n = 7) or PAP 1-2 years after first exposure (n = 3). Common pulmonary histopathologic features in these patients included intraalveolar exudate typical of alveolar proteinosis (n = 9), cholesterol clefts and granulomas (n = 10), and fibrosis (n = 9). Two patients with interstitial lung disease had pneumothoraces. Lung disease progressed following cessation of exposure in most patients and was fatal in two. Radiographic data revealed that two patients with PAP subsequently developed fibrosis and one also developed emphysematous changes. Epidemiologic investigations demonstrated the potential for exposure to respirable particles and an excess of lung abnormalities among coworkers. Conclusions: Occupational exposure to indium compounds was associated with PAP, cholesterol ester crystals and granulomas, pulmonary fibrosis, emphysema, and pneumothoraces. The available evidence suggests exposure to indium compounds causes a novel lung disease that may begin with PAP and progress to include fibrosis and emphysema, and, in some cases, premature death. Prospective studies are needed to better define the natural history and prognosis of this emerging lung disease and identify effective prevention strategies. CHEST 2012; 141(6):1512-1521
Keywords:
PULMONARY ALVEOLAR PROTEINOSIS
TIN-OXIDE
INHALATION
GRANULOMAS
PARTICLES
PNEUMONIA
TOXICITY
WORKERS
KL-6
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

Chest cover
Chest
IF:
8.6
Papers:
4.9W
Citations:
5.1W

Organization

K
Keio University
Scholars:
2.2W
Papers: 1.6W
Citations: 13
D
Duke University
Scholars:
6.3W
Papers: 5.7W
Citations: 6.5W
U
University System of Ohio
Scholars:
15.4W
Papers: 13.0W
Citations: 200
U
University of Cincinnati
Scholars:
1.8W
Papers: 1.4W
Citations: 2.2W
M
Medical University of South Carolina
Scholars:
1.6W
Papers: 1.3W
Citations: 1.4W
N
nanjing university
Scholars:
7.8W
Papers: 5.6W
Citations: 87
C
centers for disease control & prevention - usa
Scholars:
2.9W
Papers: 2.3W
Citations: 17
W
West Virginia University
Scholars:
1.4W
Papers: 1.1W
Citations: 1.2W
researcher View more organizations